𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transforming growth factor-β1 in nephrotic syndrome treated with cyclosporine and ACE inhibitors

✍ Scribed by Anna M. Wasilewska; Walentyna M. Zoch-Zwierz

Publisher
Springer
Year
2004
Tongue
English
Weight
197 KB
Volume
19
Category
Article
ISSN
0931-041X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of hepatocyte growth factor,
Expression of hepatocyte growth factor, transforming growth factor α, and transforming growth factor β 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation
✍ M Masuhara; M Yasunaga; K Tanigawa; F Tamura; S Yamashita; I Sakaida; K Okita 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

After a partial hepatectomy, TGF-a mRNA has been shown of chronic liver disease; CH, chronic hepatitis; LC, liver cirrhosis; LI, labeling index; RTto increase in hepatocytes at the time of DNA synthesis con-PCR, reverse-transcriptase polymerase chain reaction; cDNA, complementary DNA.

Transforming growth factor-β1 : A useful
Transforming growth factor-β1 : A useful tumor marker in patients with colorectal carcinoma?
✍ Alan D. Langerak; Harinder S. Garewal 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

T he report by Shim et al. 1 in this issue of Cancer presents interesting data regarding the potential use of serum transforming growth factor (TGF)-␤1 levels as a tumor marker in patients with colorectal carcinoma. Their findings suggest that TGF-␤ may be helpful in predicting extent of disease and